These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16617425)

  • 1. Computational mutagenesis studies of protein structure-function correlations.
    Masso M; Lu Z; Vaisman II
    Proteins; 2006 Jul; 64(1):234-45. PubMed ID: 16617425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate prediction of enzyme mutant activity based on a multibody statistical potential.
    Masso M; Vaisman II
    Bioinformatics; 2007 Dec; 23(23):3155-61. PubMed ID: 17977887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate prediction of stability changes in protein mutants by combining machine learning with structure based computational mutagenesis.
    Masso M; Vaisman II
    Bioinformatics; 2008 Sep; 24(18):2002-9. PubMed ID: 18632749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical geometry based prediction of nonsynonymous SNP functional effects using random forest and neuro-fuzzy classifiers.
    Barenboim M; Masso M; Vaisman II; Jamison DC
    Proteins; 2008 Jun; 71(4):1930-9. PubMed ID: 18186470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive mutagenesis of HIV-1 protease: a computational geometry approach.
    Masso M; Vaisman II
    Biochem Biophys Res Commun; 2003 May; 305(2):322-6. PubMed ID: 12745077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure, stability, and biological activity of bacteriophage T4 gene product 9 probed with mutagenesis and monoclonal antibodies.
    Kurochkina LP; Vishnevskiy AY; Zhemaeva LV; Sykilinda NN; Strelkov SV; Mesyanzhinov VV
    J Struct Biol; 2006 May; 154(2):122-9. PubMed ID: 16520061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on inhibitors of HIV protease: a target for drug design.
    Jayaraman S; Shah K
    In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1.8A X-ray structure of C95M/C1095F double mutant of tethered HIV-1 protease dimer complexed with acetyl pepstatin.
    Prashar V; Hosur MV
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1229-35. PubMed ID: 15451428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mutations on the dimer stability and the pH optimum of the human foamy virus protease.
    Sperka T; Boross P; Eizert H; Tözsér J; Bagossi P
    Protein Eng Des Sel; 2006 Aug; 19(8):369-75. PubMed ID: 16799151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective scoring function for protein sequence design.
    Liang S; Grishin NV
    Proteins; 2004 Feb; 54(2):271-81. PubMed ID: 14696189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural correlates of the temperature sensitive phenotype derived from saturation mutagenesis studies of CcdB.
    Bajaj K; Dewan PC; Chakrabarti P; Goswami D; Barua B; Baliga C; Varadarajan R
    Biochemistry; 2008 Dec; 47(49):12964-73. PubMed ID: 19006334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the functional consequences of single residue replacements in bacteriophage f1 gene V protein.
    Masso M; Mathe E; Parvez N; Hijazi K; Vaisman II
    Protein Eng Des Sel; 2009 Nov; 22(11):665-71. PubMed ID: 19690089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
    Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
    J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
    Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
    J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models.
    Steindl TM; Schuster D; Laggner C; Chuang K; Hoffmann RD; Langer T
    J Chem Inf Model; 2007; 47(2):563-71. PubMed ID: 17381173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-body scoring function for mutagenesis.
    Deutsch C; Krishnamoorthy B
    Bioinformatics; 2007 Nov; 23(22):3009-15. PubMed ID: 17921497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling.
    Frutos S; Rodriguez-Mias RA; Madurga S; Collinet B; Reboud-Ravaux M; Ludevid D; Giralt E
    Biopolymers; 2007; 88(2):164-73. PubMed ID: 17236209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How inaccuracies in protein structure models affect estimates of protein-ligand interactions: computational analysis of HIV-I protease inhibitor binding.
    Thorsteinsdottir HB; Schwede T; Zoete V; Meuwly M
    Proteins; 2006 Nov; 65(2):407-23. PubMed ID: 16941468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance.
    Alcaro S; Artese A; Ceccherini-Silberstein F; Ortuso F; Perno CF; Sing T; Svicher V
    J Chem Inf Model; 2009 Jul; 49(7):1751-61. PubMed ID: 19537723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.